Interview
Interviews are typically with authors on their recently published AJKD articles.
Between 2006 and 2016, the number of US dialysis facilities experienced steady annual growth. Recent data suggest a reversal in this trend. Varkila et al examined trends in
[...]In IgA nephropathy (IgAN), elevated levels of the circulating autoantigen galactose-deficient IgA1 are critical to disease pathogenesis. Genetic as well as in vitro, in vivo,
[...]Rituximab effectively limits the number of relapses in childhood idiopathic nephrotic syndromes (INS) and reduces exposure to corticosteroids and other immunosuppressants.
[...]Atrial fibrillation is common among patients with kidney failure treated with hemodialysis. A recent study published in AJKD by Winkelmayer et al examined the efficacy and
[...]IgA nephropathy (IgAN) is the most common immune-mediated glomerular disease worldwide. Advanced understanding of the role of complement in IgAN pathogenesis has motivated
[...]Systemic lupus erythematosus (SLE) is a chronic, multiorgan autoimmune disease, with lupus nephritis (LN) affecting up to 60% of patients. Early diagnosis and treatment are
[...]Hyperphosphatemia remains a major challenge in managing patients with kidney failure and is associated with significant morbidity and mortality. In a Mini-Review recently
[...]Chronic systemic inflammation, triggered by innate immune system activation, is a key driver of both chronic kidney disease (CKD) and associated atherosclerosis and
[...]Membranous nephropathy (MN) is characterized by a relapsing remitting course with a third of patients developing kidney failure if untreated. A recent study published in AJKD
[...]Glucagon-like peptide-1 receptor agonists and sodium/glucose cotransporter 2 (SGLT2) inhibitors can improve outcomes in patients with type 2 diabetes. Using a nationwide
[...]
